Drug intelligence / Profile preview

citrate-phosphate-dextrose-adenine

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous
01

Overview

Citrate-phosphate-dextrose-adenine (CPDA-1) is an anticoagulant and preservative solution used for the collection, storage, and preservation of human whole blood and red blood cells. It is a fixed-dose combination of five components: sodium citrate, citric acid, monobasic sodium phosphate, dextrose, and adenine. Citrate acts as an anticoagulant by chelating calcium ions, thereby preventing the clotting cascade. Phosphate serves as a buffer to maintain pH stability. Dextrose provides an energy source for red blood cell glycolysis, and adenine supports ATP synthesis to maintain cell viability. CPDA-1 extends the shelf life of stored red blood cells to approximately 35 days at 1 to 6°C. It is widely used in blood banking, transfusion medicine, and veterinary settings.

Brand names
Anticoagulant Citrate Phosphate Dextrose Adenine Solution
Other names
CPD-ACPDACPDA-1CPDA1CPDA 1CPDA-1 solutionCPDA1 solutionCPDA 1 solutionCPDA-Icitrate phosphate dextrose adeninecitrate-phosphate-dextrose-adenine solution
02

Targets

APRT (Adenine phosphoribosyltransferase)GCK (Glucokinase)

Beyond the preview

Go deeper on citrate-phosphate-dextrose-adenine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citrate-phosphate-dextrose-adenine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call